Efflux and uptake transport and gut microbial reactivation of raloxifene glucuronides. [PDF]
Uoti A +7 more
europepmc +1 more source
Anticoagulation Therapies and microRNAs in Heart Failure. [PDF]
Spartano L, Lombardi M, Foglieni C.
europepmc +1 more source
Pharmacotherapy in kidney disease: what it takes to move from general guidance to specific recommendations to stratified subgroups of patients - the tale of autosomal dominant polycystic kidney disease (ADPKD). [PDF]
Tillmann AC +3 more
europepmc +1 more source
Effects of Liver Surgery on Drug Transporters in the Liver and Remote Organs. [PDF]
Mehvar R.
europepmc +1 more source
Differential Protective Roles of c-Jun N-terminal Kinase-2 in Nonparenchymal Liver Cells and Hepatocytes During Cholestasis. [PDF]
Mohamed MR +11 more
europepmc +1 more source
Hepatitis B and chronic kidney disease: Bench to bedside. [PDF]
Singh S, Singh R, Kaul A, Goel A.
europepmc +1 more source
Conjugated bile acids in serum reflect disease severity and predict survival in chronic liver disease of humans and rats. [PDF]
Eguchi A +11 more
europepmc +1 more source
Human ABC and SLC Transporters: The Culprit Responsible for Unspecific PSMA-617 Uptake? [PDF]
Taş H +6 more
europepmc +1 more source
Furosemide, an Old Friend of Nephrologists for the Treatment of CKD: Time to Rethink the Relationship? [PDF]
Bertocchio JP.
europepmc +1 more source
Comparing Torsemide with Furosemide: Finally a Mechanistic Approach that Says, "Enough Already".
Al-Awqati Q.
europepmc +1 more source

